Active-ingredient Dossier
Nebivolol Hydrochloride
Active-ingredient Dossier for Nebivolol Hydrochloride (beta blocker). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: APO-NEBIVOLOL
- Brand: NEBILET
- Brand: NEBIVOLOL-WGR
- Brand: Nebivolol
- Brand: NEBIVOLOL VIATRIS
- Brand: NEBIVOLOL-RJIC
- Therapeutic area: Cardiology
What is
Nebivolol Hydrochloride Nebivolol Hydrochloride is a beta blocker.
Australian brands containing
Nebivolol Hydrochloride — APO-NEBIVOLOL — NEBILET — NEBALOC — NEBIVOLOL — NEBIVOLOL-WGR — NEPITEN — LOBIVON — Nebivolol — NEBIVOLOL VIATRIS — NEBIVOLOL-RJIC
Therapeutic areas
Nebivolol Hydrochloride is registered in cardiology, with 10 brands containing the ingredient.
Sponsor landscape
The ingredient is marketed by seven sponsors: Arrotex Pharmaceuticals, A Menarini, Southern Cross Pharma, Pharmacor, Alphapharm, and Helix Pharmaceuticals.
PBS and regulatory activity
Two brands containing Nebivolol Hydrochloride have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2009, and no AusPARs have been recorded for this ingredient.